Supplementary
. In addition to T98G cells, 5-AcTMF downregulates Tyrosine 705-phosphorylated STAT3 (p-STAT3), BCL-2 and BCL-xL in GBM 8401 and U-87 MG cell lines. Human GBM cell lines GBM 8401 and U-87 MG were treated with 5-AcTMF (0, 50, and 100 μM) for 24 h, followed by immunoblotting for the levels of p-STAT3, total STAT3, BCL-2, and BCL-xL. The levels of β-actin were used as the control for equal loading. Based upon these results, it is noteworthy that 5-AcTMF-induced downregulation of p-STAT3, as well as STAT3 transcriptional targets BCL-2 and BCL-xL, appears to be universal in human GBM cell lines, suggesting that blockade of the STAT3-BCL-2/BCL-xL signaling axis represents a general mechanism of action of 5-AcTMF to elicit GBM cell apoptosis.
